CN Patent

CN108366957A — 用于治疗心血管疾病的吉卡宾组合

Assigned to Yao Shi Treatment Co · Expires 2018-08-03 · 8y expired

What this patent protects

本发明提供了经配制以包括他汀类和吉卡宾的药物组合物，其中所述组合物可用于治疗、预防或减少涉及升高水平的LDL胆固醇、甘油三酯或二者的心血管和代谢适应症的症状。

USPTO Abstract

本发明提供了经配制以包括他汀类和吉卡宾的药物组合物，其中所述组合物可用于治疗、预防或减少涉及升高水平的LDL胆固醇、甘油三酯或二者的心血管和代谢适应症的症状。

Drugs covered by this patent

atrasentan-hydrochloride (ATRASENTAN HYDROCHLORIDE)

Patent Metadata

Patent number: CN108366957A
Jurisdiction: CN
Classification: —
Expires: 2018-08-03
Drug substance claim: No
Drug product claim: No
Assignee: Yao Shi Treatment Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.